Dscern Health Ventures is an early-stage healthcare investment firm. We back the founders rebuilding software and services for the providers operating outside the hospital — and we underwrite from inside the workflow.
Dscern Health Ventures is a healthcare investment firm, established 2025. We were founded on the principle that lasting investment success comes from disciplined analysis and independent judgment — even when that means a contrarian view.
The next decade of digital health will be defined by the founders who serve the outpatient buyer — and by the investors with the clinical depth and operator experience to back them. Our name reflects how we work: we read carefully, hold contrarian views when the evidence calls for them, and act on conviction earned in the workflow.
To perceive and understand something with clarity, often after careful observation or thought.
Exercising discipline when short-term trends cloud judgment.
Backing founders with resilience and conviction — not just credentials.
Open communication and honest acknowledgment of risks — in every report and every conversation.
The American healthcare system is reconfiguring around acuity. The largest cost center — hospital care — is consolidating and getting more expensive. Routine, scheduled, and chronic care is migrating to specialized outpatient settings, where the technology is being rebuilt from scratch.
80%+ of U.S. surgeries already happen outpatient. CMS keeps expanding the ambulatory surgery center list — 560 procedures were added for 2026 alone. Even the highest-acuity specialties are moving: cardiology procedures in ASCs are up 230% since 2018, spine +200%, orthopedics +31%. The shift is structural, not cyclical.
A 2024 JAMA analysis estimated $148B in annual U.S. savings from clinically appropriate site-of-care shifts — achievable today, with technology that already exists. The same researchers project AI adoption could drive an additional 5–10% in system-wide net savings. Acute-care-at-home alone could shift up to $265B of Medicare services out of facilities.
Modern software penetration at independent ambulatory sites sits below 5%. The gap persists because outsiders can't underwrite a workflow they don't operate inside — and most digital-health investors still build for hospital buyers with 18-month enterprise sales cycles. Coordination, eligibility, care-transition, and AI-driven workflows are what unlocks the next tranche. They haven't been built yet.
Sources: CMS National Health Expenditure Accounts · MedPAC (2025) · Sahni, Cutler et al., JAMA Network Open (2024) · ASC Association · Vizient (2025) · McKinsey home-care analysis.
We invest where we can be most useful — at Seed and Series A, alongside the founders building software and services for outpatient providers. The portfolio is concentrated by design, built around three principles.
70%+ of ambulatory surgery centers are independent and physician-owned. We back the software and services that make these operators stronger — alongside the clinicians who run them, not in place of them. Partnership, not control.
A small, sector-specific portfolio means every founder has access to the same 150+ outpatient facility relationships, the same clinical partners, and the same commercialization muscle. We'd rather be the strategic investor on a focused book than another logo on a long list.
Clinical partners validate the evidence and regulatory pathway. Operators understand how outpatient providers actually buy. Diligence happens where care happens — which is the only place a real edge exists in healthcare investing.
Ambient documentation that listens during the visit and writes the note. Prior-authorization automation. AI-assisted imaging triage. Surgical scheduling and planning. The repetitive clinical and administrative load that pulls clinicians away from patients — automated away.
Longitudinal records that travel with the procedure. Claims-to-clinical integration. Outpatient-specific analytics. The connective tissue that outpatient providers need but can't build themselves.
Chronic disease management for heart failure, kidney disease, diabetes, and COPD. Post-surgical recovery monitoring that enables same-day discharge. Evidence-based behavioral health tools with established reimbursement.
Virtual-first specialty care models — cardiology, dermatology, mental health, women's health, gastroenterology. Acute-care-at-home programs. New delivery models that meet patients where care is going.
Dscern was founded by operators of the outpatient ecosystem. The relationship network we use to source, pilot, and exit was built before the firm existed — and it compounds with every portfolio company we add.
Surgery centers, multi-site clinics, and surgical practices built and operated during our team's prior tenure. Founders see us as a strategic investor delivering pilots and reference customers — not just capital.
ASC operator relationships surface frontline tech needs before they hit the market. Clinical partners pressure-test candidates before diligence concludes — granting proprietary deal flow at attractive valuations.
Portfolio companies pilot inside the network's facilities. The result is clinical and commercial evidence health systems require before enterprise purchase — and the founders are the first to have it.
Reference-grade case studies from real pilots become the evidence base for enterprise sales and exit narratives — shortening time-to-revenue and lifting strategic value at exit.
The core team has worked together for more than a decade across healthcare investing, clinical practice, and ASC operations. That history shows up in how we run diligence, support founders, and underwrite long-duration outcomes — and how we behave with LPs through the inevitable cycles.
Investment management as an act of service — to our investors, the providers we partner with, and the patients who deserve a better system.The Dscern principle
Most of what gets done at Dscern starts with a direct introduction or a thoughtful first email. We respond personally — usually within 48 hours.
We share materials after a brief conversation. First close targeted for September 2026, final close in Q1 2028.
lp@dscerncapital.comSend a short note on what you're building, your customer profile, and why now. No deck required to start.
founders@dscerncapital.com